Literature DB >> 17613203

Malignant peripheral nerve sheath tumors.

Gaurav Gupta1, Allen Maniker.   

Abstract

Malignant peripheral nerve sheath tumors (MPNSTs) are rare soft tissue sarcomas of ectomesenchymal origin. The World Health Organization coined the term MPNST to replace previous heterogeneous and often confusing terminology, such as "malignant schwannoma," "malignant neurilemmoma," "neurogenic sarcoma," and "neurofibrosarcoma." Malignant peripheral nerve sheath tumors arise from major or minor peripheral nerve branches or sheaths of peripheral nerve fibers, and are derived from Schwann cells or pluripotent cells of neural crest origin. The Schwann cell is thought to be the major contributor to the formation of benign as well as malignant neoplasms of the nerve sheath. While this fact remains essentially true, the identity of cell of origin of the MPNST remains elusive, and has not yet been conclusively identified. It has been suggested that these tumors may have multiple cell line origins. In this review, the authors discuss the epidemiology, diagnosis, management, and treatment of MPNSTs.

Entities:  

Mesh:

Year:  2007        PMID: 17613203     DOI: 10.3171/foc.2007.22.6.13

Source DB:  PubMed          Journal:  Neurosurg Focus        ISSN: 1092-0684            Impact factor:   4.047


  31 in total

1.  Malignant peripheral nerve sheath tumour presenting as a pneumothorax.

Authors:  A Abbas; H Jones; G T Kingston; A Zurek
Journal:  Br J Radiol       Date:  2011-10       Impact factor: 3.039

2.  Early-stage malignant peripheral nerve sheath tumour arising from a solitary neurofibroma.

Authors:  T Hyodo; Y Sugawara; K Sakayama; K Kito
Journal:  Br J Radiol       Date:  2012-02       Impact factor: 3.039

3.  Late and multifocal presentations of malignant peripheral nerve sheath tumours following radiotherapy.

Authors:  Lara Jones; Lloyd Bradley
Journal:  BMJ Case Rep       Date:  2015-07-07

Review 4.  PleiotRHOpic: Rho pathways are essential for all stages of Neural Crest development.

Authors:  Philippe Fort; Eric Théveneau
Journal:  Small GTPases       Date:  2014-03-10

Review 5.  Intracerebellar malignant nerve sheath tumor in a child: case report and review of literature.

Authors:  Krishna Chaitanya Joshi; Hariprakash Chakravarthy; Nirmala Subramanian
Journal:  Childs Nerv Syst       Date:  2014-08-21       Impact factor: 1.475

6.  Malignant peripheral nerve sheath tumours of the spine: clinical manifestations, classification, treatment, and prognostic factors.

Authors:  Bin Zhu; Xiaoguang Liu; Zhongjun Liu; Shaomin Yang; Hung-I Liao; Liang Jiang; Feng Wei
Journal:  Eur Spine J       Date:  2011-12-03       Impact factor: 3.134

7.  Malignant transformation of acoustic neuroma/vestibular schwannoma 10 years after gamma knife stereotactic radiosurgery.

Authors:  Andreas K Demetriades; Nicholas Saunders; Peter Rose; Cyril Fisher; Jeremy Rowe; Robert Tranter; Carl Hardwidge
Journal:  Skull Base       Date:  2010-09

8.  Pediatric and adult malignant peripheral nerve sheath tumors: an analysis of data from the surveillance, epidemiology, and end results program.

Authors:  E Susan Amirian; J Clay Goodman; Pamela New; Michael E Scheurer
Journal:  J Neurooncol       Date:  2014-01-05       Impact factor: 4.130

9.  Poly (ADP) ribose polymerase inhibition: A potential treatment of malignant peripheral nerve sheath tumor.

Authors:  Christine M Kivlin; Kelsey L Watson; Ghadah A Al Sannaa; Roman Belousov; Davis R Ingram; Kai-Lieh Huang; Caitlin D May; Svetlana Bolshakov; Sharon M Landers; Azad Abul Kalam; John M Slopis; Ian E McCutcheon; Raphael E Pollock; Dina Lev; Alexander J Lazar; Keila E Torres
Journal:  Cancer Biol Ther       Date:  2015-12-09       Impact factor: 4.742

10.  Malignant Triton tumor in the retroperitoneal space associated with neurofibromatosis type 1: a case study.

Authors:  Sojun Hoshimoto; Zenichi Morise; Chinatsu Takeura; Masahiro Ikeda; Tadashi Kagawa; Yoshinao Tanahashi; Yasuhiro Okabe; Yoshikazu Mizoguchi; Atsushi Sugioka
Journal:  Rare Tumors       Date:  2009-12-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.